Accès ouvert
2026
article
OpenAlex
Bao-Han Ly, Uilke Brouwer, Laura Hesse, Kuldeep Kumawat et autres
Asthma is a heterogeneous airway disease characterized by chronic inflammation, airway hyperresponsiveness (AHR), and airway remodeling. Previously, we identified Protocadherin-1 (PCDH1) as a susceptibility gene for AHR, a hallmark of asthma. PCDH1 is an adhesion molecule, highly expressed in the airway epithelium. …
nl, gb, pt, be
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Yidan Sun, Elise M. A. Slob, Lieke C. E. Noij, Tatiana Karp et autres
nl
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Bao-Han Ly, Djoke van Gosliga, Georgia N. Ithakisiou, Gimano D. Amatngalim et autres
PCDH1 is a susceptibility gene for airway hyperresponsiveness, a hallmark of asthma. PCDH1 is highly expressed in the airway epithelium, localized to cell-cell contact sites. Previous analysis of Pcdh1-KO mice suggested enrichment of hillock-squamous differentiation in the airways of those mice. However, …
nl
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Bao-Han Ly, Uilke Brouwer, Laura E. Hesse, Arjen H. Petersen et autres
Asthma is a heterogeneous airway disease. We previously identified PCDH1 as a susceptibility gene for airway hyperresponsiveness (AHR), a hallmark of asthma. PCDH1 is an adhesion molecule, highly expressed in the airway epithelium. However, its role in AHR, airway inflammation, and remodeling …
nl, be
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Tessa E. Gillett, Aurore C. A. Gay, Martin Banchero, Marijn Berg et autres
The airway epithelium is altered in patients with asthma, with reduced barrier function and goblet cell metaplasia. Recently, single cell RNA-seq has identified 15+ distinct airway epithelial cell types in the Human Lung Cell Atlas, but it is unknown whether these newly …
nl, gb, pa
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
Jelmer Vlasma, Aurore C. A. Gay, Martin Banchero, Judith M. Vonk et autres
Introduction: Asthma is a heterogeneous lung disease, characterized by remodeled airways and mucus hypersecretion. Previously, we showed that the airway composition is changed in patients with asthma, showing more mucus-producing cells such as goblet and mucous ciliated cells compared to healthy controls. …
nl
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Aurore C. A. Gay, Martin Banchero, Orestes A. Carpaij, Tessa Kole et autres
Background In patients with asthma, respiratory syncytial virus (RSV) infections can cause disease exacerbation by infecting the epithelial layer of the airways, inducing subsequent immune response. The type I interferon antiviral response of epithelial cells upon RSV infection is found to be …
nl
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Zaid W. Elhusseini, Dmitry Khalenkow, Andy Lan, Thys van der Molen et autres
BACKGROUND: Asthma is stratified into type 2-high and type 2-low inflammatory phenotypes. Limited success has been achieved in developing drugs that target type 2-low inflammation. Previous studies have linked IL-6 signaling to severe asthma. IL-6 cooperates with soluble-IL-6Rα to activate cell signaling …
nl, gb, it, de, us
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Kingsley Okechukwu Nwozor, Tillie‐Louise Hackett, Chen Xi Yang, Aurore C. A. Gay et autres
Background: Impaired airway epithelial barrier function and repair are thought to be key drivers in chronic obstructive pulmonary disease (COPD) pathology, however, the mechanisms involved remain not fully understood. Objective: Assess bronchial epithelial cell differentiation in an organoid model by COPD severity …
ca, nl
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Zaid W. Elhusseini, Dmitry Khalenkow, Andy Lan, Maarten van den Berge et autres
Background: Asthma is clinically stratified into type 2-high and type 2-low asthma. Limited success has been achieved in developing drugs that target type-2 low inflammation. Previous studies have linked IL-6 signaling to type 2-low asthma. Objective: We sought to study the role …
nl
(code pays fourni par la source)
Accès ouvert
2023
preprint
OpenAlex
Aurore C. A. Gay, Martin Banchero, Orestes A. Carpaij, Tessa Kole et autres
Abstract In patients with asthma, respiratory syncytial virus (RSV) infections can cause disease exacerbations by infecting the epithelial layer of the airways, inducing an innate and adaptive immune response. The type-I interferon antiviral response of epithelial cells upon RSV infection is found …
nl
(code pays fourni par la source)
2022
conference-abstract
OpenAlex
Aurore C. A. Gay, Marijn Berg, Orestes A. Carpaij, Uilke Brouwer et autres
Rationale: Respiratory syncytial virus (RSV) infection can cause asthma exacerbations. Most - but not all - studies showed that the type-I interferon dependent antiviral response induced by the epithelial cells after RSV infection is reduced in asthma. The molecular mechanisms responsible for …
nl, de, be
(code pays fourni par la source)